Metly

www.meetmetly.com ↗ ·Barcelona ·Pre-seed

Metly is an AI-powered intelligence platform for the pharmaceutical industry, automating competitive intelligence, deal screening, partner identification and portfolio monitoring by aggregating regulatory filings, clinical databases and partnership signals (over 35,000 licences from 550+ companies). Founded in Barcelona in 2024, it raised an oversubscribed €520K pre-seed in July 2025 led by Encomenda — reported as the largest women-led pre-seed in Spain that year — and is expanding into the US and Chinese markets.

Founded

2024

Founders

Total funds raised

€520K

SectorsHealthtech & Bio, AI & Data, Enterprise Software, Pharma, SaaS Start-up MapHealthtech & Bio › R&D tools & software for life sciences

Suggest a correction

Founders

Anna Torrents Saldo

Co-founder & CEO

Graeme Harris

Co-founder & CTO

Lydia Taranilla

Co-founder

Global models 4

AlphaSense

United States · www.alpha-sense.com ↗

AI market and competitive intelligence platform sold by subscription. It pulls together filings, expert calls and deal data, and pharma business-development teams are among its biggest users.

$1.4BComparable

United States · h1.co ↗

SaaS intelligence platform for pharma and life-sciences companies. It combines clinical-trial, publication and regulatory data so teams can spot partners, experts and competitive signals.

$223MComparable

Causaly

United Kingdom · www.causaly.com ↗

AI research and intelligence platform sold to pharma companies. It mines biomedical literature and clinical data to speed up target, competitor and portfolio decisions.

$93MComparable

Klue

Canada · klue.com ↗

AI competitive-intelligence SaaS that automatically gathers and monitors competitor signals for enterprise teams. It is the same automated-CI subscription model but not specific to pharma.

$83MComparable